TreeWAS – Variant ID: rs71277158

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C61 Malignant neoplasm of prostate	0.000	0.000	1.000
C60-C63 Malignant neoplasms of male genital organs	0.000	0.631	0.369
C62 Malignant neoplasm of testis	0.000	0.717	0.282
C63 Malignant neoplasm of other and unspecified male genital organs	0.000	0.735	0.265
C62.1 Descended testis	0.000	0.779	0.220
C60 Malignant neoplasm of penis	0.000	0.785	0.215
C62.0 Undescended testis	0.000	0.797	0.203
C62.9 Testis, unspecified	0.000	0.797	0.202
C63.9 Male genital organ, unspecified	0.000	0.810	0.190
C63.8 Overlapping lesion of male genital organs	0.000	0.810	0.190
C63.7 Other specified male genital organs	0.000	0.810	0.190
C63.2 Scrotum	0.000	0.810	0.190
C63.1 Spermatic cord	0.000	0.810	0.190
C63.0 Epididymis	0.000	0.810	0.190
C60.8 Overlapping lesion of penis	0.000	0.845	0.154
C60.2 Body of penis	0.000	0.845	0.154
C60.1 Glans penis	0.000	0.845	0.154
C60.0 Prepuce	0.000	0.845	0.154
C60.9 Penis, unspecified	0.001	0.895	0.104
Z85.4 Personal history of malignant neoplasm of genital organs	0.000	0.953	0.047
Z45.2 Adjustment and management of vascular access device	0.000	0.973	0.027
C18.0 Caecum	0.000	0.991	0.009
B18.2 Chronic viral hepatitis C	0.000	0.991	0.009
B18 Chronic viral hepatitis	0.000	0.993	0.007
K60.2 Anal fissure, unspecified	0.000	0.993	0.007
R47.0 Dysphasia and aphasia	0.000	0.993	0.007
B18.1 Chronic viral hepatitis B without delta-agent	0.000	0.993	0.007
C34.3 Lower lobe, bronchus or lung	0.000	0.994	0.006
F29 Unspecified nonorganic psychosis	0.006	0.994	0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.006	0.994	0.000
F20 Schizophrenia	0.005	0.995	0.000
B18.9 Chronic viral hepatitis, unspecified	0.000	0.995	0.005
B18.8 Other chronic viral hepatitis	0.000	0.995	0.005
B18.0 Chronic viral hepatitis B with delta-agent	0.000	0.995	0.005
F22 Persistent delusional disorders	0.005	0.995	0.000
F25 Schizoaffective disorders	0.005	0.995	0.000
F20.0 Paranoid schizophrenia	0.005	0.995	0.000
H02.8 Other specified disorders of eyelid	0.000	0.995	0.005
F22.0 Delusional disorder	0.005	0.995	0.000
R47.1 Dysarthria and anarthria	0.000	0.995	0.005
F20.9 Schizophrenia, unspecified	0.005	0.995	0.000
R47 Speech disturbances, not elsewhere classified	0.000	0.995	0.005
F25.0 Schizoaffective disorder, manic type	0.004	0.995	0.000
T45.0 Antiallergic and antiemetic drugs	0.005	0.995	0.000
Z29.2 Other prophylactic chemotherapy	0.004	0.996	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.004	0.996	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.004	0.996	0.000
F28 Other nonorganic psychotic disorders	0.004	0.996	0.000
F24 Induced delusional disorder	0.004	0.996	0.000
F21 Schizotypal disorder	0.004	0.996	0.000
C34 Malignant neoplasm of bronchus and lung	0.000	0.996	0.004
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.004	0.996	0.000
J35.8 Other chronic diseases of tonsils and adenoids	0.000	0.996	0.004
T46.4 Angiotensin-converting-enzyme inhibitors	0.004	0.996	0.000
F25.9 Schizoaffective disorder, unspecified	0.004	0.996	0.000
F20.8 Other schizophrenia	0.004	0.996	0.000
F20.6 Simple schizophrenia	0.004	0.996	0.000
F20.5 Residual schizophrenia	0.004	0.996	0.000
F20.4 Postschizophrenic depression	0.004	0.996	0.000
F20.3 Undifferentiated schizophrenia	0.004	0.996	0.000
F20.2 Catatonic schizophrenia	0.004	0.996	0.000
F20.1 Hebephrenic schizophrenia	0.004	0.996	0.000
B15-B19 Viral hepatitis	0.000	0.996	0.004
T45.5 Anticoagulants	0.004	0.996	0.000
M23.32 Other meniscus derangements (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.004	0.996	0.000
F22.9 Persistent delusional disorder, unspecified	0.004	0.996	0.000
F22.8 Other persistent delusional disorders	0.004	0.996	0.000
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)	0.000	0.996	0.004
Z42.0 Follow-up care involving plastic surgery of head and neck	0.000	0.996	0.004
F25.8 Other schizoaffective disorders	0.004	0.996	0.000
F25.2 Schizoaffective disorder, mixed type	0.004	0.996	0.000
F25.1 Schizoaffective disorder, depressive type	0.004	0.996	0.000
Y84.2 Radiological procedure and radiotherapy	0.000	0.996	0.004
F23 Acute and transient psychotic disorders	0.004	0.996	0.000
M06.34 Rheumatoid nodule (Hand)	0.004	0.996	0.000
C34.1 Upper lobe, bronchus or lung	0.000	0.996	0.004
B17 Other acute viral hepatitis	0.000	0.996	0.004
C34.0 Main bronchus	0.000	0.996	0.004
T47.1 Other antacids and anti-gastric-secretion drugs	0.004	0.996	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.004	0.996	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.004	0.996	0.000
B17.1 Acute hepatitis C	0.000	0.996	0.004
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.004	0.996	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.003	0.996	0.000
M25.56 Pain in joint (Lower leg)	0.000	0.996	0.004
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.997	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
T46.7 Peripheral vasodilators	0.003	0.997	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.997	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.997	0.000
C34.8 Overlapping lesion of bronchus and lung	0.000	0.997	0.003
T45.9 Primarily systemic and haematological agent, unspecified	0.003	0.997	0.000
T45.8 Other primarily systemic and haematological agents	0.003	0.997	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.997	0.000
T45.6 Fibrinolysis-affecting drugs	0.003	0.997	0.000
T45.4 Iron and its compounds	0.003	0.997	0.000
T45.3 Enzymes, not elsewhere classified	0.003	0.997	0.000
T45.2 Vitamins, not elsewhere classified	0.003	0.997	0.000
C34.9 Bronchus or lung, unspecified	0.000	0.997	0.003
B15 Acute hepatitis A	0.000	0.997	0.003
T45.1 Antineoplastic and immunosuppressive drugs	0.003	0.997	0.000
B19 Unspecified viral hepatitis	0.000	0.997	0.003
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.003	0.997	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
B16 Acute hepatitis B	0.000	0.997	0.003
T43.3 Phenothiazine antipsychotics and neuroleptics	0.003	0.997	0.000
T46.1 Calcium-channel blockers	0.003	0.997	0.000
R00.8 Other and unspecified abnormalities of heart beat	0.000	0.997	0.003
T36 Poisoning by systemic antibiotics	0.003	0.997	0.000
F23.8 Other acute and transient psychotic disorders	0.003	0.997	0.000
F23.3 Other acute predominantly delusional psychotic disorders	0.003	0.997	0.000
F23.2 Acute schizophrenia-like psychotic disorder	0.003	0.997	0.000
F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia	0.003	0.997	0.000
F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia	0.003	0.997	0.000
C45.9 Mesothelioma, unspecified	0.000	0.997	0.003
M06.3 Rheumatoid nodule	0.003	0.997	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
B17.9 Acute viral hepatitis, unspecified	0.000	0.997	0.003
B17.8 Other specified acute viral hepatitis	0.000	0.997	0.003
B17.2 Acute hepatitis E	0.000	0.997	0.003
B17.0 Acute delta-(super) infection of hepatitis B carrier	0.000	0.997	0.003
I42.0 Dilated cardiomyopathy	0.003	0.997	0.000
K11.5 Sialolithiasis	0.000	0.997	0.003
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.003	0.997	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.003	0.997	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
T50.8 Diagnostic agents	0.003	0.997	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
T47.7 Emetics	0.003	0.997	0.000
T47.6 Antidiarrhoeal drugs	0.003	0.997	0.000
T47.5 Digestants	0.003	0.997	0.000
T47.4 Other laxatives	0.003	0.997	0.000
T47.3 Saline and osmotic laxatives	0.003	0.997	0.000
T47.2 Stimulant laxatives	0.003	0.997	0.000
T47.0 Histamine H(2)-receptor antagonists	0.003	0.997	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.003	0.997	0.000
Y84.1 Kidney dialysis	0.000	0.997	0.003
T50.7 Analeptics and opioid receptor antagonists	0.003	0.997	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
T50.5 Appetite depressants	0.003	0.997	0.000
T50.4 Drugs affecting uric acid metabolism	0.003	0.997	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.003	0.997	0.000
T50.1 Loop [high-ceiling] diuretics	0.003	0.997	0.000
T50.0 Mineralocorticoids and their antagonists	0.003	0.997	0.000
M06.30 Rheumatoid nodule (Multiple sites)	0.003	0.997	0.000
M06.37 Rheumatoid nodule (Ankle and foot)	0.003	0.997	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
M06.9 Rheumatoid arthritis, unspecified	0.000	0.997	0.003
R47.8 Other and unspecified speech disturbances	0.000	0.997	0.003
M22.4 Chondromalacia patellae	0.000	0.997	0.003
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.000	0.997	0.003
B15.9 Hepatitis A without hepatic coma	0.000	0.997	0.003
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.000	0.997	0.003
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.000	0.997	0.003
B15.0 Hepatitis A with hepatic coma	0.000	0.997	0.002
T36.0 Penicillins	0.003	0.997	0.000
F23.9 Acute and transient psychotic disorder, unspecified	0.002	0.997	0.000
F31.9 Bipolar affective disorder, unspecified	0.003	0.997	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.003	0.997	0.000
W18.5 Trade and service area	0.000	0.997	0.003
B19.9 Unspecified viral hepatitis without coma	0.000	0.997	0.002
B19.0 Unspecified viral hepatitis with coma	0.000	0.997	0.002
K12.3 Oral mucositis (ulcerative)	0.000	0.997	0.003
W18.3 Sports and athletics area	0.000	0.997	0.003
C34.2 Middle lobe, bronchus or lung	0.000	0.997	0.002
F43.0 Acute stress reaction	0.003	0.997	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.003	0.997	0.000
Y84 Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure	0.000	0.997	0.003
I07.1 Tricuspid insufficiency	0.003	0.997	0.000
B16.2 Acute hepatitis B without delta-agent with hepatic coma	0.000	0.997	0.002
B16.1 Acute hepatitis B with delta-agent (coinfection) without hepatic coma	0.000	0.997	0.002
B16.0 Acute hepatitis B with delta-agent (coinfection) with hepatic coma	0.000	0.997	0.002
R90.0 Intracranial space-occupying lesion	0.003	0.997	0.000
T36.9 Systemic antibiotic, unspecified	0.002	0.997	0.000
T36.8 Other systemic antibiotics	0.002	0.997	0.000
T36.7 Antifungal antibiotics, systemically used	0.002	0.997	0.000
T36.6 Rifamycins	0.002	0.997	0.000
T36.5 Aminoglycosides	0.002	0.997	0.000
T36.4 Tetracyclines	0.002	0.997	0.000
T36.3 Macrolides	0.002	0.997	0.000
T36.2 Chloramphenicol group	0.002	0.997	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.002	0.997	0.000
Z34.8 Supervision of other normal pregnancy	0.000	0.997	0.003
T38.1 Thyroid hormones and substitutes	0.002	0.997	0.000
Y84.8 Other medical procedures	0.000	0.997	0.003
M06.39 Rheumatoid nodule (Site unspecified)	0.002	0.998	0.000
M06.38 Rheumatoid nodule (Other)	0.002	0.998	0.000
M06.36 Rheumatoid nodule (Lower leg)	0.002	0.998	0.000
M06.35 Rheumatoid nodule (Pelvic region and thigh)	0.002	0.998	0.000
M06.33 Rheumatoid nodule (Forearm)	0.002	0.998	0.000
M06.32 Rheumatoid nodule (Upper arm)	0.002	0.998	0.000
M06.31 Rheumatoid nodule (Shoulder region)	0.002	0.998	0.000
T43.9 Psychotropic drug, unspecified	0.002	0.998	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.998	0.000
C45 Mesothelioma	0.000	0.998	0.002
M43.16 Spondylolisthesis (Lumbar region)	0.002	0.998	0.000
B16.9 Acute hepatitis B without delta-agent and without hepatic coma	0.000	0.998	0.002
O62.2 Other uterine inertia	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
T37.5 Antiviral drugs	0.002	0.998	0.000
T37.4 Anthelminthics	0.002	0.998	0.000
T37.3 Other antiprotozoal drugs	0.002	0.998	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
T37.1 Antimycobacterial drugs	0.002	0.998	0.000
T37.0 Sulphonamides	0.002	0.998	0.000
T41.5 Therapeutic gases	0.002	0.998	0.000
T41.4 Anaesthetic, unspecified	0.002	0.998	0.000
T41.3 Local anaesthetics	0.002	0.998	0.000
T41.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
T41.1 Intravenous anaesthetics	0.002	0.998	0.000
T41.0 Inhaled anaesthetics	0.002	0.998	0.000
T43.6 Psychostimulants with abuse potential	0.002	0.998	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.002	0.998	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
T44.0 Anticholinesterase agents	0.002	0.998	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
T48.5 Anti-common-cold drugs	0.002	0.998	0.000
T48.4 Expectorants	0.002	0.998	0.000
T48.3 Antitussives	0.002	0.998	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
T48.0 Oxytocic drugs	0.002	0.998	0.000
T49.9 Topical agent, unspecified	0.002	0.998	0.000
T49.8 Other topical agents	0.002	0.998	0.000
T49.7 Dental drugs, topically applied	0.002	0.998	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
T49.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
T49.3 Emollients, demulcents and protectants	0.002	0.998	0.000
T49.2 Local astringents and local detergents	0.002	0.998	0.000
T49.1 Antipruritics	0.002	0.998	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
C18 Malignant neoplasm of colon	0.000	0.998	0.002
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.000	0.998	0.002
J30.1 Allergic rhinitis due to pollen	0.000	0.998	0.002
T38.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
T38.7 Androgens and anabolic congeners	0.002	0.998	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
T38.5 Other oestrogens and progestogens	0.002	0.998	0.000
T38.4 Oral contraceptives	0.002	0.998	0.000
T38.2 Antithyroid drugs	0.002	0.998	0.000
T38.0 Glucocorticoids and synthetic analogues	0.002	0.998	0.000
Z57.2 Occupational exposure to dust	0.000	0.998	0.002
M79.19 Myalgia (Site unspecified)	0.002	0.998	0.000
C45.7 Mesothelioma of other sites	0.000	0.998	0.002
K65.8 Other peritonitis	0.000	0.998	0.002
T43.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.998	0.000
T43.2 Other and unspecified antidepressants	0.002	0.998	0.000
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.000	0.998	0.002
Y44.2 Anticoagulants	0.000	0.998	0.002
C22.9 Liver, unspecified	0.000	0.998	0.002
D22.6 Melanocytic naevi of upper limb, including shoulder	0.002	0.998	0.000
C45.0 Mesothelioma of pleura	0.000	0.998	0.002
T40.2 Other opioids	0.002	0.998	0.000
E16.2 Hypoglycaemia, unspecified	0.000	0.998	0.002
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.002	0.998	0.000
T40.8 Lysergide [LSD]	0.002	0.998	0.000
T40.7 Cannabis (derivatives)	0.002	0.998	0.000
T40.5 Cocaine	0.002	0.998	0.000
T40.3 Methadone	0.002	0.998	0.000
T40.1 Heroin	0.002	0.998	0.000
T40.0 Opium	0.002	0.998	0.000
Y84.7 Blood-sampling	0.000	0.998	0.002
Y84.5 Insertion of gastric or duodenal sound	0.000	0.998	0.002
Y84.3 Shock therapy	0.000	0.998	0.002
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.000	0.998	0.002
W18 Other fall on same level	0.000	0.998	0.002
C18.5 Splenic flexure	0.000	0.998	0.002
F31.0 Bipolar affective disorder, current episode hypomanic	0.002	0.998	0.000
Z50.5 Speech therapy	0.000	0.998	0.002
C45.2 Mesothelioma of pericardium	0.000	0.998	0.002
C45.1 Mesothelioma of peritoneum	0.000	0.998	0.002
C67.6 Ureteric orifice	0.000	0.998	0.002
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
F31.7 Bipolar affective disorder, currently in remission	0.002	0.998	0.000
G91.9 Hydrocephalus, unspecified	0.000	0.998	0.002
Y84.9 Medical procedure, unspecified	0.000	0.998	0.002
F31 Bipolar affective disorder	0.002	0.998	0.000
Y84.4 Aspiration of fluid	0.000	0.998	0.002
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.000	0.998	0.002
C18.9 Colon, unspecified	0.000	0.998	0.002
E13.9 Without complications	0.002	0.998	0.000
K13.7 Other and unspecified lesions of oral mucosa	0.002	0.998	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.002	0.998	0.000
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.000	0.998	0.002
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.000	0.998	0.002
T40.6 Other and unspecified narcotics	0.002	0.998	0.000
M06.98 Rheumatoid arthritis, unspecified (Other)	0.000	0.998	0.002
C18.7 Sigmoid colon	0.000	0.998	0.002
C18.8 Overlapping lesion of colon	0.000	0.998	0.002
C67.4 Posterior wall of bladder	0.000	0.998	0.002
Z34.9 Supervision of normal pregnancy, unspecified	0.000	0.998	0.002
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
Y84.0 Cardiac catheterisation	0.000	0.998	0.002
M81.40 Drug-induced osteoporosis (Multiple sites)	0.000	0.998	0.002
C18.1 Appendix	0.000	0.998	0.002
Z29 Need for other prophylactic measures	0.002	0.998	0.000
S72.00 Fracture of neck of femur (closed)	0.000	0.998	0.002
R32 Unspecified urinary incontinence	0.000	0.998	0.002
C30 Malignant neoplasm of nasal cavity and middle ear	0.000	0.998	0.002
W18.9 Unspecified place	0.000	0.998	0.002
W18.8 Other specified place	0.000	0.998	0.002
W18.4 Street and highway	0.000	0.998	0.002
W18.2 School, other institution and public administrative area	0.000	0.998	0.002
W18.0 Home	0.000	0.998	0.002
W18.7 Farm	0.000	0.998	0.002
W18.6 Industrial and construction area	0.000	0.998	0.002
W18.1 Residential institution	0.000	0.998	0.002
C18.2 Ascending colon	0.000	0.998	0.002
C67.8 Overlapping lesion of bladder	0.000	0.998	0.002
I35.1 Aortic (valve) insufficiency	0.000	0.998	0.002
T42.1 Iminostilbenes	0.002	0.998	0.000
J35 Chronic diseases of tonsils and adenoids	0.000	0.998	0.002
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.002	0.998	0.000
T40.4 Other synthetic narcotics	0.002	0.998	0.000
C18.4 Transverse colon	0.000	0.998	0.002
F31.8 Other bipolar affective disorders	0.002	0.998	0.000
I11.0 Hypertensive heart disease with (congestive) heart failure	0.002	0.998	0.000
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.000	0.998	0.002
C31 Malignant neoplasm of accessory sinuses	0.000	0.998	0.002
C33 Malignant neoplasm of trachea	0.000	0.998	0.002
Z34 Supervision of normal pregnancy	0.000	0.998	0.002
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.002	0.998	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.002	0.998	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.002	0.998	0.000
T42.3 Barbiturates	0.002	0.998	0.000
T42.2 Succinimides and oxazolidinediones	0.002	0.998	0.000
Z29.1 Prophylactic immunotherapy	0.002	0.998	0.000
C69.3 Choroid	0.000	0.998	0.002
N71.9 Inflammatory disease of uterus, unspecified	0.000	0.998	0.002
C38 Malignant neoplasm of heart, mediastinum and pleura	0.000	0.998	0.002
F17.2 Dependence syndrome	0.002	0.998	0.000
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.002	0.998	0.000
C37 Malignant neoplasm of thymus	0.000	0.998	0.002
K11 Diseases of salivary glands	0.000	0.998	0.002
C67.3 Anterior wall of bladder	0.000	0.998	0.002
F30.0 Hypomania	0.002	0.998	0.000
I11.9 Hypertensive heart disease without (congestive) heart failure	0.002	0.998	0.000
K11.9 Disease of salivary gland, unspecified	0.000	0.998	0.002
C67 Malignant neoplasm of bladder	0.000	0.998	0.002
C30.0 Nasal cavity	0.000	0.998	0.001
K11.1 Hypertrophy of salivary gland	0.000	0.998	0.002
F31.6 Bipolar affective disorder, current episode mixed	0.001	0.998	0.000
I63.3 Cerebral infarction due to thrombosis of cerebral arteries	0.000	0.998	0.002
J35.0 Chronic tonsillitis	0.000	0.998	0.002
Z29.9 Prophylactic measure, unspecified	0.001	0.998	0.000
C18.3 Hepatic flexure	0.000	0.998	0.001
G90.9 Disorder of autonomic nervous system, unspecified	0.000	0.998	0.002
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.001	0.998	0.000
C30.1 Middle ear	0.000	0.998	0.001
K11.8 Other diseases of salivary glands	0.000	0.998	0.002
L08.9 Local infection of skin and subcutaneous tissue, unspecified	0.002	0.998	0.000
R73.0 Abnormal glucose tolerance test	0.000	0.998	0.002
T42.0 Hydantoin derivatives	0.001	0.998	0.000
Z45 Adjustment and management of implanted device	0.000	0.998	0.001
W18.09 Other fall on same level: Home: During unspecified activity	0.000	0.998	0.001
W18.04 Other fall on same level, Home , While resting, sleeping, eating or engaging in other vital activities	0.000	0.998	0.001
W18.22 Other fall on same level; School, other institution and public administrative area; While working for income	0.000	0.998	0.001
W18.49 Other fall on same level; Street and highway; During unspecified activity	0.000	0.998	0.001
W18.48 Other fall on same level; Street and highway; While engaged in other specified activities	0.000	0.998	0.001
W18.89 Other fall on same level; Other specified places; During unspecified activity	0.000	0.998	0.001
W18.99 Other fall on same level; Unspecified place; During unspecified activity	0.000	0.998	0.001
W18.93 Other fall on same level; Unspecified place; While engaged in other types of work	0.000	0.998	0.001
Z29.8 Other specified prophylactic measures	0.001	0.998	0.000
C66 Malignant neoplasm of ureter	0.000	0.998	0.002
J35.3 Hypertrophy of tonsils with hypertrophy of adenoids	0.000	0.998	0.001
Z80.5 Family history of malignant neoplasm of urinary tract	0.000	0.998	0.002
J35.9 Chronic disease of tonsils and adenoids, unspecified	0.000	0.998	0.001
C31.9 Accessory sinus, unspecified	0.000	0.998	0.001
C31.8 Overlapping lesion of accessory sinuses	0.000	0.998	0.001
C31.3 Sphenoidal sinus	0.000	0.998	0.001
C31.2 Frontal sinus	0.000	0.998	0.001
C31.1 Ethmoidal sinus	0.000	0.998	0.001
C31.0 Maxillary sinus	0.000	0.998	0.001
C39.9 Ill-defined sites within the respiratory system	0.000	0.998	0.001
C39.8 Overlapping lesion of respiratory and intrathoracic organs	0.000	0.998	0.001
C39.0 Upper respiratory tract, part unspecified	0.000	0.998	0.001
C64-C68 Malignant neoplasms of urinary tract	0.000	0.998	0.002
C38.8 Overlapping lesion of heart, mediastinum and pleura	0.000	0.999	0.001
C38.3 Mediastinum, part unspecified	0.000	0.999	0.001
C38.2 Posterior mediastinum	0.000	0.999	0.001
C38.1 Anterior mediastinum	0.000	0.999	0.001
C38.0 Heart	0.000	0.999	0.001
C67.1 Dome of bladder	0.000	0.999	0.001
K11.4 Fistula of salivary gland	0.000	0.999	0.001
K11.0 Atrophy of salivary gland	0.000	0.999	0.001
C64 Malignant neoplasm of kidney, except renal pelvis	0.000	0.999	0.001
M43.02 Spondylolysis (Cervical region)	0.001	0.999	0.000
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.001	0.999	0.000
K11.2 Sialoadenitis	0.000	0.999	0.001
Z34.0 Supervision of normal first pregnancy	0.000	0.999	0.001
M70.46 Prepatellar bursitis-Lower Leg	0.001	0.999	0.000
C67.7 Urachus	0.000	0.999	0.001
D68.2 Hereditary deficiency of other clotting factors	0.001	0.999	0.000
C38.4 Pleura	0.000	0.999	0.001
I35.8 Other aortic valve disorders	0.000	0.999	0.001
I35.2 Aortic (valve) stenosis with insufficiency	0.000	0.999	0.001
I61.5 Intracerebral haemorrhage, intraventricular	0.000	0.999	0.001
K11.6 Mucocele of salivary gland	0.000	0.999	0.001
Q60.0 Renal agenesis, unilateral	0.001	0.999	0.000
M46.96 Inflammatory spondylopathy, unspecified (Lumbar region)	0.001	0.999	0.000
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.001	0.999	0.000
J35.2 Hypertrophy of adenoids	0.000	0.999	0.001
N34.2 Other urethritis	0.000	0.999	0.001
Z45.9 Adjustment and management of unspecified implanted device	0.000	0.999	0.001
F30 Manic episode	0.001	0.999	0.000
F69 Unspecified disorder of adult personality and behaviour	0.001	0.999	0.000
S82.10 Fracture of upper end of tibia (closed)	0.000	0.999	0.001
C69.9 Eye, unspecified	0.000	0.999	0.001
F30.2 Mania with psychotic symptoms	0.001	0.999	0.000
I61.4 Intracerebral haemorrhage in cerebellum	0.000	0.999	0.001
T42.4 Benzodiazepines	0.001	0.999	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.001	0.999	0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.000	0.999	0.001
C21.0 Anus, unspecified	0.000	0.999	0.001
G54.9 Nerve root and plexus disorder, unspecified	0.001	0.999	0.000
I61.2 Intracerebral haemorrhage in hemisphere, unspecified	0.000	0.999	0.001
W13.9 Unspecified place	0.000	0.999	0.001
C68 Malignant neoplasm of other and unspecified urinary organs	0.000	0.999	0.001
F43 Reaction to severe stress, and adjustment disorders	0.001	0.999	0.000
I35 Nonrheumatic aortic valve disorders	0.000	0.999	0.001
C18.6 Descending colon	0.000	0.999	0.001
C67.0 Trigone of bladder	0.000	0.999	0.001
H60.9 Otitis externa, unspecified	0.000	0.999	0.001
I61.9 Intracerebral haemorrhage, unspecified	0.000	0.999	0.001
K11.3 Abscess of salivary gland	0.000	0.999	0.001
K74.3 Primary biliary cirrhosis	0.001	0.999	0.000
M43.1 Spondylolisthesis	0.001	0.999	0.000
I07 Rheumatic tricuspid valve diseases	0.001	0.999	0.000
F45.2 Hypochondriacal disorder	0.001	0.999	0.000
O62.3 Precipitate labour	0.001	0.999	0.000
Z45.3 Adjustment and management of implanted hearing device	0.000	0.999	0.001
Z45.0 Adjustment and management of cardiac pacemaker	0.001	0.999	0.000
I61 Intracerebral haemorrhage	0.000	0.999	0.001
Z57 Occupational exposure to risk-factors	0.000	0.999	0.001
I35.9 Aortic valve disorder, unspecified	0.000	0.999	0.001
U51.1 Previously admitted to a psychiatric hospital of the provider	0.001	0.999	0.000
C69 Malignant neoplasm of eye and adnexa	0.000	0.999	0.001
F30.8 Other manic episodes	0.001	0.999	0.000
F30.1 Mania without psychotic symptoms	0.001	0.999	0.000
F43.1 Posttraumatic stress disorder	0.001	0.999	0.000
J35.1 Hypertrophy of tonsils	0.000	0.999	0.001
N71.1 Chronic inflammatory disease of uterus	0.000	0.999	0.001
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.001	0.999	0.000
T39.4 Antirheumatics, not elsewhere classified	0.001	0.999	0.000
T39.2 Pyrazolone derivatives	0.001	0.999	0.000
C19 Malignant neoplasm of rectosigmoid junction	0.000	0.999	0.001
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.000	0.999	0.001
C46 Kaposi's sarcoma	0.000	0.999	0.001
I11 Hypertensive heart disease	0.001	0.999	0.000
F60-F69 Disorders of adult personality and behaviour	0.001	0.999	0.000
F45.9 Somatoform disorder, unspecified	0.001	0.999	0.000
K35.0 Acute appendicitis with generalised peritonitis	0.001	0.999	0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.000	0.999	0.001
C68.9 Urinary organ, unspecified	0.000	0.999	0.001
C68.8 Overlapping lesion of urinary organs	0.000	0.999	0.001
C68.1 Paraurethral glands	0.000	0.999	0.001
C68.0 Urethra	0.000	0.999	0.001
F43.8 Other reactions to severe stress	0.001	0.999	0.000
G37.9 Demyelinating disease of central nervous system, unspecified	0.001	0.999	0.000
O68.2 Labour and delivery complicated by foetal heart rate anomaly with meconium in amniotic fluid	0.000	0.999	0.001
Z57.5 Occupational exposure to toxic agents in other industries	0.000	0.999	0.001
C73 Malignant neoplasm of thyroid gland	0.000	0.999	0.001
M43.18 Spondylolisthesis (Sacral and sacrococcygeal region)	0.001	0.999	0.000
M43.15 Spondylolisthesis (Thoracolumbar region)	0.001	0.999	0.000
M43.14 Spondylolisthesis (Thoracic region)	0.001	0.999	0.000
M43.13 Spondylolisthesis (Cervicothoracic region)	0.001	0.999	0.000
M43.12 Spondylolisthesis (Cervical region)	0.001	0.999	0.000
M43.11 Spondylolisthesis (Occipito-atlanto-axial region)	0.001	0.999	0.000
M43.10 Spondylolisthesis (Multiple sites in spine)	0.001	0.999	0.000
S27.00 Traumatic pneumothorax (without open wound into thoracic cavity)	0.001	0.999	0.000
C67.5 Bladder neck	0.000	0.999	0.001
G90.2 Horner's syndrome	0.000	0.999	0.001
I07.9 Tricuspid valve disease, unspecified	0.001	0.999	0.000
I07.8 Other tricuspid valve diseases	0.001	0.999	0.000
I07.2 Tricuspid stenosis with insufficiency	0.001	0.999	0.000
I07.0 Tricuspid stenosis	0.001	0.999	0.000
I61.0 Intracerebral haemorrhage in hemisphere, subcortical	0.000	0.999	0.001
K60.0 Acute anal fissure	0.000	0.999	0.001
Z54.0 Convalescence following surgery	0.000	0.999	0.001
F64 Gender identity disorders	0.001	0.999	0.000
F30-F39 Mood [affective] disorders	0.001	0.999	0.000
I50.0 Congestive heart failure	0.001	0.999	0.000
I61.8 Other intracerebral haemorrhage	0.000	0.999	0.001
I61.6 Intracerebral haemorrhage, multiple localised	0.000	0.999	0.001
I61.3 Intracerebral haemorrhage in brain stem	0.000	0.999	0.001
K11.7 Disturbances of salivary secretion	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations